QR kód

Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma

Abstract Background This retrospective analysis of data from clinical trials in metastatic urothelial carcinoma (mUC) was conducted to determine baseline patient characteristics associated with long-term survival (LTS) following treatment with immune checkpoint inhibitors. Methods Data for this anal...

Celý popis

Uloženo v:
Hlavní autoři: Marie Alt, Carlos Stecca, Yian Lin, Gbenga Kazeem, Erik T. Goluboff, Srikala S. Sridhar
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2023-09-01
Edice:BMC Cancer
Témata:
Durvalumab
Immune checkpoint inhibitor
Long-term survival
Multivariable analysis
Predictive factors
Univariable analysis
On-line přístup:https://doi.org/10.1186/s12885-023-11380-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky